UNIVERSAL HEALTH SERVICES INC (UHS) earnings date, results and what the price requires
NYSE · SEC CIK 0000352915 · SEC filings checked Oct 16, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 28, 2026 | $4.64B | $358.4M | $5.98 | Filing |
| Mar 31, 2026 | Apr 28, 2026 | $4.50B | $348.7M | $5.65 | Filing |
| Dec 31, 2025 | Feb 26, 2026 | $4.49B | $445.9M | $7.01 | Filing |
| Sep 30, 2025 | Oct 28, 2025 | $4.50B | $373.0M | $5.86 | Filing |
| Jun 30, 2025 | Jul 29, 2025 | $4.28B | $353.2M | $5.43 | Filing |
| Mar 31, 2025 | Apr 29, 2025 | $4.10B | $316.7M | $4.80 | Filing |
| Dec 31, 2024 | Feb 27, 2025 | $4.11B | $332.4M | $4.94 | Filing |
| Sep 30, 2024 | Oct 25, 2024 | $3.96B | $258.7M | $3.80 | Filing |
What would UNIVERSAL HEALTH SERVICES INC have to report for its valuation to change?
At $187.36, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about -8.2% a year, to $16.02. On that path the next quarter needs diluted EPS near $5.38, against $5.86 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | -8.2% | -8.2% |
| EPS needed in final year | $16.02 | $16.02 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. UHS goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.